院長の業績

主な学術活動

  • ・腎交感神経デナベーション治療における臨床応用
  • ・原発性アルドステロン症の副腎静脈サンプリング検査や薬物治療の研究
  • ・腎血管性高血圧症へのカテーテル治療の研究
  • ・ヒト循環血中単核球キマーゼ依存アンジオテンシンⅡ活性の臨床研究
  • ・循環器臨床研究ネットワークでの多施設共同前向き観察試験の解析
  • ・脂質関連遺伝子や循環器疾患炎症ケモカインの研究
  • ・旅行医学に関する研究
  • ・救急医療に関する研究
原著:31本(筆頭・責任著者として英文16本)
総説、Letter、Correspondence:15本(筆頭著者として英文7本、和文5本)
症例報告:17本(筆頭・責任著者として英文7本、和文5本)
学会発表:筆頭演者として国内44回、国際16回
講演:64回
(2025年3月30日)
Differentiating Between Fibromuscular Dysplasia and Takayasu Arteritis in a Patient With Juvenile Renovascular Hypertension and Marked Hypokalemia Effectively Treated With Percutaneous Transluminal Renal Angioplasty.
Ishii A, Okamura K, Morisaki S, Momota Y, Yamashita A, Hatsuse K, Kono K, Sako H, Udo A, Taniguchi K, Koseki T, Arai T, Yodogawa Y, Oba Y, Hirayama S, Inoue M, Imamura I.
J Clin Med Res. 2025 Mar;17(3):174-180.
The Impact on Patient Prognosis of Changes to the Method of Notifying Staff About Accepting Patients With Out-of-Hospital Cardiac Arrest.
Inoue Y, Okamura K, Shimada H, Watakabe S, Hirayama S, Hirata M, Kusuda A, Matsumoto A, Inoue M, Matsuishi E, Yamada M, Iwanaga S, Narumi S, Nakayama S, Sako H, Udo A, Taniguchi K, Morisaki S, Ide S, Nomoto Y, Miura SI, Imakyure O, Imamura I.
J Clin Med Res. 2024 Dec;16(12):578-588.
Addition of Sacubitril/Valsartan to Mineralocorticoid Receptor Antagonist Therapy in Primary Aldosteronism: Effects on Plasma Aldosterone Concentration and Plasma Renin Activity
Keisuke Okamura, Masatoshi Matsushima, Yosuke Takamiya, Tetsu Okuda, Hideto Sako, Akihiro Udo, Kenichiro Taniguchi, Shogo Morisaki, Ichiro Imamura, Hidenori Urata, Shin-ichiro Miura
J Clin Med Res. 2024;16(10):509-517
Underestimation of renal artery lumen diameter by computed tomography has consequences for the assessment of patient eligibility for renal denervation.
Okamura K, Matsushima M, Satou S, Ishiya A, Shimada H, Okuda T, Imamura I, Urata H, Miura SI.
Hypertens Res. 2024 Oct;47(10):2784-2785.
Impact of renal denervation on quality of life (How does renal denervation contribute to improving hypertension treatment affected by poor medication adherence?).
Okamura K, Shimada H, Imazato K, Sako H, Udo A, Taniguchi K, Morisaki S, Imamura I, Urata H, Arima H, Miura SI.
Hypertens Res. 2024 Oct;47(10):2652-2658.
Effects of renal denervation on blood pressure in patients with hypertension: a latest systematic review and meta-analysis of randomized sham-controlled trials.
Ogoyama Y, Abe M, Okamura K, Tada K, Katsurada K, Shibata S, Kai H, Rakugi H, Node K, Yokoi H, Kario K, Arima H.
Hypertens Res. 2024 Oct;47(10):2745-2759.
Resistance exercise has an antihypertensive effect comparable to that of aerobic exercise in hypertensive patients: a meta-analysis of randomized controlled trials.
Hypertens Res. 2025 Feb;48(2):733-743.
Morita H, Abe M, Suematsu Y, Uehara Y, Koyoshi R, Fujimi K, Ideishi A, Takata K, Kato Y, Hirata T, Yahiro E, Morito N, Kitajima K, Satoh A, Yoshimura C, Ishida S, Okutsu S, Takahashi K, Shinohara Y, Sakaguchi T, Katsuki S, Tada K, Fujii T, Funakoshi S, Hu Y, Satoh T, Ohnishi H, Okamura K, Mizuno H, Arakawa K, Asayama K, Ohtsubo T, Ishigami T, Shibata S, Fujita T, Munakata M, Ohishi M, Ichihara A, Katsuya T, Mukoyama M, Rakugi H, Node K, Arima H, Miura SI.
Differences in the effects of exercise on blood pressure depending on the physical condition of the subject and the type of exercise: a systematic review and meta-analysis
Hypertens Res. 2025 Feb;48(2):720-732.
Yasunori Suematsu, Hidetaka Morita, Makiko Abe, Yoshinari Uehara, Rie Koyoshi, Kanta Fujimi, Akihito Ideishi, Kohei Takata, Yuta Kato, Tetsuo Hirata, Eiji Yahiro, Natsumi Morito, Ken Kitajima, Yuiko Yano, Atsushi Satoh, Chikara Yoshimura, Shintaro Ishida, Shota Okutsu, Koji Takahashi, Yukiko Shinohara, Takashi Sakaguchi, Shiori Katsuki, Kazuhiro Tada, Takako Fujii , Shunsuke Funakoshi , Yaopeng Hu , Tomonori Satoh, Hirofumi Ohnishi, Keisuke Okamura, Hiroyuki Mizuno, Kimika Arakawa, Kei Asayama, Toshio Ohtsubo, Tomoaki Ishigami, Shigeru Shibata, Takayuki Fujita, Masanori Munakata, Mitsuru Ohishi, Atsuhiro Ichihara, Tomohiro Katsuya, Masashi Mukoyama, Hiromi Rakugi, Koichi Node, Hisatomi Arim, Shin-Ichiro Miura
生活習慣病外来の遠隔オンライン診療導入
岡村 圭祐, 有江 環, 今里 圭介, 立山 陽子, 佐光 英人, 有働 晃博, 谷口 賢一郎, 守﨑 勝悟, 山元 芙美, 山元 謙太郎, 小川 健一, 山元 博, 今村 一郎
臨牀と研究(0021-4965)101巻9号 Page1139-1144(2024.9)
院外心肺停止患者受入れ時における院内一斉放送での多職種人材確保の試み
井上 陽一, 岡村 圭祐, 平山 しほり, 渡壁 忍, 平田 真智子, 松本 有沙, 楠田 綾香, 井上 美樹, 松尾 春奈, 岩永 幸子, 鳴海 翔悟, 中山 紫季, 福永 亮大, 池田 飛鳥, 野元 康行, 岸川 圭嗣, 今村 一郎
臨牀と研究(0021-4965)100巻12号 Page1493-1498(2023.12)
Catheter-based ultrasound renal denervation in patients with resistant hypertension: the randomized, controlled REQUIRE trial
Kazuomi Kario, Yoshiaki Yokoi, Keisuke Okamura, Masahiko Fujihara, Yukako Ogoyama, Eiichiro Yamamoto, Hidenori Urata, Jin-Man Cho, Chong-Jin Kim, Seung-Hyuk Choi, Keisuke Shinohara, Yasushi Mukai, Tomokazu Ikemoto, Masato Nakamura, Shuichi Seki, Satoaki Matoba, Yoshisato Shibata, Shigeo Sugawara, Kazuhiko Yumoto, Kouichi Tamura, Fumiki Yoshihara, Satoko Nakamura, Woong Chol Kang, Taro Shibasaki, Keigo Dote, Hiroyoshi Yokoi, Akiko Matsuo, Hiroshi Fujita, Toshiyuki Takahashi, Hyun-Jae Kang, Yasushi Sakata, Kazunori Horie, Naoto Inoue, Ken-Ichiro Sasaki, Takafumi Ueno, Hirofumi Tomita, Yoshihiro Morino, Yuhei Nojima, Chan Joon Kim, Tomoaki Matsumoto, Hisashi Kai, Shinsuke Nanto
Hypertens Res. 2022 Feb;45(2):221-231.
Intravascular Ultrasound Can Be Used to Locate Nerves, but not Confirm Ablation, During Renal Sympathetic Denervation.
Okamura K, Satou S, Kato Y, Kogata Y, Matsushima M, Shirai K, Urata H.
J Clin Med Res. 2021 Dec;13(12):556-562.
Elevated chymase-dependent angiotensin II-forming activity in circulating mononuclear leukocytes was observed in the patient of atrial fibrillation.
Okamura K, Okuda T, Takamiya Y, Shirai K, Urata H.
Heart Vessels. 2020 Aug;35(8):1116-1124.
Add-on aliskiren treatment can decrease blood pressure but requires attention to risks of renal impairment and hyperkalemia Chikushi Anti-Hypertension Trial-Rasilez® (CHAT-Ras).
Okamura K, Takamiya Y, Mori K, Shirai K, Urata H.
Clin Exp Hypertens. 2020 Aug 17;42(6):545-552.
Efficacy and safety of a combination antihypertensive drug (olmesartan plus azelnidipine): “Issues with hypertension studies in real-world practice”.
Okamura K, Yano Y, Takamiya Y, Shirai K, Urata H.
Clin Exp Hypertens. 2020 Jul 3;42(5):438-448.
非弁膜症心房細動患者における直接作用型経口抗凝固薬リバーロキサバン内服の実地診療下での患者アドヒアランスと満足度調査:CHAT-Xa study
足達宣、宮崎元康、山本智彦、衛藤聡、岡村圭祐、浦田秀則、CHAT-JRN会員
心臓 vol.52 No4 2020
Comprehensive Efficacy of the Dipeptidyl Peptidase 4 Inhibitor Alogliptin in Practical Clinical Settings: A Prospective Multi-Center Interventional Observational Study.
Takamiya Y, Kobayashi K, Kudo T, Okuda T, Okamura K, Shirai K, Urata H; Chikushi Cardiovascular Research Network.
J Clin Med Res. 2020 Jul;12(7):423-430.
Inappropriate direct oral anticoagulant dosing in atrial fibrillation patients is associated with prescriptions for outpatients rather than inpatients: a single-center retrospective cohort study.
Miyazaki M, Matsuo K, Uchiyama M, Nakamura Y, Sakamoto Y, Misaki M, Tokura K, Jimi S, Okamura K, Adachi S, Yamamoto T, Shirai K, Urata H, Imakyure O.
J Pharm Health Care Sci. 2020 Feb 11:6:2.
Multicenter prospective observational study of teneligliptin, a selective dipeptidyl peptidase-4 inhibitor, in patients with poorly controlled type 2 diabetes: Focus on glycemic control, hypotensive effect, and safety Chikushi Anti-Diabetes Mellitus Trial-Teneligliptin (CHAT-T).
Takamiya Y, Okamura K, Shirai K, Okuda T, Kobayashi K, Urata H.
Clin Exp Hypertens. 2020;42(3):197-204.
循環器科医の為の超選択的副腎静脈サンプリングマニュアル“副腎静脈サンプリングの普及の為に”)
岡村圭祐、浦田秀則
臨床と研究(97巻5号, 2020年5月)
A patient with bilateral primary aldosteronism refractory to oral eplerenone who responded to esaxerenone with increased renin activity
Okamura K, Matsushima M, Yamamoto F, Takamiya Y, Okuda T, Shirai K, Okamura K, Urata H
Am J Case Rep. 2020 Jan 7:21:e920615.
自宅退院後に呼吸状態が悪化し、夏型過敏性肺炎と診断された1例
西野 菜々子, 岡村 圭祐, 佐伯 瞳, 竹田 悟志, 柴田 優果, 奥田 哲, 高宮 陽介, 池内 伸光, 上田 裕介, 石井 寛, 岡村 克佑, 永田 忍彦, 浦田 秀則
臨牀と研究(0021-4965)97巻1号 Page109-112(2020.01)
High Fib4 index in patients with suspected NASH is associated with elevation of chymase-dependent angiotensin II-forming activity in circulating mononuclear leucocytes.
Okamura K, Okuda T, Takamiya Y, Shirai K, Urata H.
Heart Vessels. 2019 Sep;34(9):1559-1569.
Increase of chymase-dependent angiotensin II-forming activity in circulating mononuclear leukocytes after acute myocardial infarction chymase activity after acute myocardial infarction.
Okamura K, Okuda T, Shirai K, Urata H.
Heart Vessels. 2019 Jul;34(7):1148-1157.
Investigation of a Dipeptidyl Peptidase-4 Inhibitor/Thiazolidinedione Combination Drug for Patients With Type 2 Diabetes and Poor Glycemic Control: Difficulty With Patient Enrollment.
Okamura K, Shirai K, Miyazaki M, Okuda T, Takamiya Y, Goto M, Urata H.
J Clin Med Res. 2019 Feb;11(2):89-97.
Prospective single-arm observational study of human chymase inhibitor Polygonum hydropiper L in subjects with hypertension.
Okamura K, Kuroda R, Nagata K, Urata H.
Clin Exp Hypertens. 2019;41(8):717-725.
Observation of renal sympathetic nerves by intravascular ultrasound.
Satou S, Okamura K, Konishi R, Shirai K, Urata H.
Hypertens Res. 2019 Jul;42(7):1092-1094.
Simplifying adrenal vein sampling for cardiologists “In the New Era of Catheter Treatment for Hypertension”.
Okamura K, Urata H.
Hypertens Res. 2019 Jan;42(1):117-119.
A Case of Primary Aldosteronism Due to A Primary Adrenal Adenoma Diagnosed by Segmental Adrenal Venous Sampling (S-AVS) Using a Modified Catheter System and Lateral Cine Angiography.
Okamura K, Okuda T, Fukuda Y, Takamiya Y, Shirai K, Miyajima S, Ishii T, Urata H.
Am J Case Rep. 2019 Feb 2;20:139-145.
Successful Depressor Effect Concomitant with Complete Normalization of High Renin and Aldosterone Profile by Percutaneous Transluminal Renal Angioplasty in a Patient with Acute Exacerbated Heart Failure with Preserved Ejection Fraction.
Takamiya Y, Okamura K, Shirai K, Urata H.
Am J Case Rep. 2019 Nov 16;20:1684-1690.
Two Years Efficacy of Paclitaxel-Coated Balloon Dilation for In-Stent Renal Artery Restenosis Due to Takayasu Arteritis.
Yamamoto T, Shirai K, Okamura K, Urata H.
Am J Case Rep. 2019 Jul 25;20:1089-1093.
Successful Depressor Effect Concomitant with Complete Normalization of High Renin and Aldosterone Profile by Percutaneous Transluminal Renal Angioplasty in a Patient with Acute Exacerbated Heart Failure with Preserved Ejection Fraction.
Takamiya Y, Okamura K, Shirai K, Urata H.
Am J Case Rep. 2019 Nov 16;20:1684-1690.
Improvement of Diurnal Blood Pressure Variation by Azilsartan.
Okamura K, Shirai K, Okuda T, Urata H.
J Clin Med Res. 2018 Jan;10(1):41-49.
The Prevalence of Japanese Outpatients with Hypertension Who Meet the Definition of Treatment Resistant Hypertension and Are Eligible for Enrolment in Clinical Trials of Endovascular Ultrasound Renal Denervation.
Okamura K, Shirai K, Okuda T, Urata H.
Intern Med. 2018 Jan 1;57(1):1-12.
Positive correlation between blood pressure or heart rate and chymase-dependent angiotensin II-forming activity in circulating mononuclear leukocytes measured by new ELISA.
Okamura K, Okuda T, Shirai K, Urata H.
Clin Exp Hypertens. 2018;40(2):112-117.
Prospective direct comparison of antihypertensive effect and safety between high-dose amlodipine or indapamide in hypertensive patients uncontrolled by standard doses of angiotensin receptor blockers and amlodipine.
Okamura K, Shirai K, Totake N, Okuda T, Urata H.
Clin Exp Hypertens. 2018;40(2):99-106.
Association between medication adherence and illness perceptions in atrial fibrillation patients treated with direct oral anticoagulants: An observational cross-sectional pilot study.
Miyazaki M, Nakashima A, Nakamura Y, Sakamoto Y, Matsuo K, Goto M, Uchiyama M, Okamura K, Mitsutake R, Urata H, Kamimura H, Imakyure O.
PLoS One. 2018 Sep 28;13(9)
Effect of Angiotensin-Converting Enzyme Inhibitor/Calcium Antagonist Combination Therapy on Renal Function in Hypertensive Patients With Chronic Kidney Disease: Chikushi Anti-Hypertension Trial – Benidipine and Perindopril.
Okuda T, Okamura K, Shirai K, Urata H.
J Clin Med Res. 2018 Feb;10(2):117-124.
Anticipated expansion of a new approach to treating hypertension without medication by catheter-based renal denervation.
Okamura K, Urata H.
J Thorac Dis. 2018 Sep;10(Suppl 26):S3266-S3270.
海外からの旅行客の心肺停止、急性心筋梗塞症例を経験して 急増する訪日観光客への対応
岡村 圭祐, 奥田 哲, 安部 大介, 谷口 裕美, 重金 勇太, 猿渡 恵子, 山田 摂子, 渡邉 直美, 松尾 邦浩, 白井 和之, 浦田 秀則
臨牀と研究 (0021-4965)95巻11号 Page1254-1258(2018.11)
Reduction of Blood Pressure Following After Renal Artery Adventitia Stripping During Total Nephroureterectomy: Potential Effect of Renal Sympathetic Denervation.
Okamura K, Satou S, Setojima K, Shono S, Miyajima S, Ishii T, Shirai K, Urata H.
Am J Case Rep. 2018 May 16;19:567-572.
Persistent Primary Aldosteronism Despite Iatrogenic Adrenal Hemorrhage After Adrenal Vein Sampling.
Okamura K, Okuda T, Shirai K, Abe I, Kobayashi K, Ishii T, Haraoka S, Urata H.
J Clin Med Res. 2018 Jan;10(1):66-71. Epub 2017 Dec 1.
Ventricular Septal Perforation after Acute Myocardial Infarction with Severe Inflammation: Three Case Reports
Okamura Keisuke (Department of Cardiology, National Kyushu Medical Center), Mori Etsuo, Nakamura Toshihiro
福岡大学医学紀要 (0385-9347)44巻2号 Page91-96(2017.09)
一般旅客機を使用した転院の構想から搬送の実際まで (致死性不整脈による心肺停止蘇生後症例での経験より)
岡村圭祐 奥田哲 平塚裕也 猿渡恵子 重金勇太 小渕弥生 山田摂子 原田信子 渡邉直美 久保伸子 江頭好美 山本たも 下村武司 葉瀬垣光 松尾邦浩 白井和之 浦田秀則
臨床と研究 94巻9号 (1140-1147) 2017年9月
Heart Rate and Blood Pressure Changes in Four Healthy Volunteers During Commercial Flight
Okamura Keisuke, Okuda Tetsu, Hiratsuka Yuuya, Shigekane Yuuta, Saruwatari Keiko, Urata Hidenori
Therapeutic Research.2016;37(12):1167-1174
【心血管病予防における機能性食品の役割】正常高値からI度高血圧症例でのヒトキマーゼ抑制を介した紅タデスプラウト服用降圧作用(解説/特集)
浦田 秀則, 黒田 理恵子, 芳賀 慶一郎, 奥田 哲, 岡村 圭祐, 井手 はるみ, 遠竹 奈央, 田邉 カオリ
機能性食品と薬理栄養 (1348-2564)10巻3号 Page108-112(2016.10)
収縮機能が低下した心不全の血圧管理
奥田哲、岡村圭祐、浦田秀則
これだけは知っておきたい 日常診療で遭遇する心血管合併症を有する高血圧の管理 2016年5月 医薬ジャーナル社
Prevalence and Characteristics of Treatment-Resistant Hypertension among Hypertensive Japanese Outpatients.
Okamura, K. and Urata, H. (2015)
International Journal of Clinical Medicine.2015; Vol.6 No.9.
Anti-hypertensive action and safety of candesartan / Hydrochlorothiazid combined drug in uncontrolled hypertensive patients: A prospective multicenter observational study (CHAT-E study)
Okamura K, Urata H,
Therapeutic Research.2015; 36(5):439-448
【腎デナベーションの今】交感神経とレニン-アンジオテンシン系はどう関連するか?(解説/特集)
岡村 圭祐, 浦田 秀則
Heart View (1342-6591)19巻5号 Page490-494(2015.05)
A case of primary aldosteronism who experienced cardiopulmonary arrest, was resuscitated and cured
Yosuke Takamiya, MD, PhD, Ken Kitajima, MD, PhD, Kazumitsu Kubota, MD, Kenzo Matsumoto, MD, Shunichiro Sumi, MD, Keisuke Okamura, MD, Ken Mori, MD, Hideaki Tojo, MD, Keijiro Saku, MD, PhD, FJCC, Hidenori Urata, MD, PhD, FJCC
Journal of Cardiology Cases Volume 9, Issue 2, February 2014, Pages 63–66
Differential Action of Four Long Acting Calcium Channel Blockers on Heart Rate and Renal Function
Tojo H, Sumi S, Okuda T, Arimura T, Okamura K, Matsumoto K, Takamiya Y, Mitsutake R, Kitajima K, Mori K, Saku K, Urata H.
Therapeutic Research.2013,34(1) :93-104
レニン・アンジオテンシン・アルドステロン(RAA)系のホットスポット 心不全-心臓のカタストロフィーにキマーゼとRAA系はどのように関与しているか
岡村 圭祐, 浦田 秀則
血圧(1340-4598)19巻1号 Page32-37(2012.01)
管理不良高血圧症例でのイルベサルタンの有効降圧と安全性 多施設共同前向き観察研究CHAT-A1y(Chikushi Anti-hypertension Trial-Avapro)
松本 研三, 角 俊一郎, 高宮 陽介, 岡村 圭祐, 森 憲, 北島 研, 久保田 和充, 東條 秀明, 浦田 秀則
血圧.2012,19(10):912-922
Beneficial effect of combination therapy comprising angiotensin Ⅱ receptor blocker plus calcium channel blocker on plasma adiponectin levels
Inoue Y, Kakuma T, Nonaka Y, Sumi S, Okamura K, Kodama S, Ando C, Niimura H, Miyoshi K, Tsuchiya Y, Yamanouchi Y, Urata H
Clin Exp Hypertension.2010,32(1):21-28
Additive antihypertensive and antihypertrophic effects of long-acting Ca blockers in uncontrolled hypertensive patients with angiotensin-receptor blocker based treatment
Kodama S, Inoue Y, Miyoshi K, Sumi S, Okamura K, Tojo H, Ando C, Niimura H, Tsuchiya Y, Mihara H, Yamanouchi Y, Urata H.
Int Heart J.2009,50(5):555-570
冠攣縮性狭心症患者の長期予後に及ぼすCa拮抗薬と硝酸薬併用の効果
三好恵、井上裕紀子、児玉直、角俊一郎、岡村圭祐、新村英也、安藤知恵、山之内良雄、浦田秀則
Prog.Med. 2009,29(3):831-837
Ratio of LDL- to HDL-associated platelet-activating factor acetylhydrolase may be a marker of inflammation in patients with paroxysmal atrial fibrillation.
Okamura K, Miura S, Zhang B, Uehara Y, Matsuo K, Kumagai K, Saku K.
Circ J. 2007 Feb;71(2):214-9.
Successful Intensive Lipid-lowering Therapy Using Atorvastatin Stabilizes Coronary Artery Plaque as Assessed by Multi-detector Row Computed Tomography
Mitsutake Ryoko, Miura Shin-ichiro, Okamura Keisuke, Niimura Hideya, Kawamura Akira, Saku Keijiro
Internal Medicine (0918-2918)46-12 Page859-863(2007.07)
Changes in total lipid profiles assessed by analytical capillary isotachophoresis throughout the acute phase of myocardial infarction
Okamura K, Miura S, Zhang B, Nishikawa H, Matsuo K, Shirai K, Saku K.
Int J Cardiol. 2006 Apr 4;108(2):264-6.
アゼルニジピンのLDLに対する抗酸化作用 キャピラリー電気泳動法による評価
谷川宏之, 三浦伸一郎, 岡村圭祐, 西川宏明, 上原吉就, 張波, 朔啓二郎
Prog.Med. 2006,26(7):1661-1664
Combined treatment with statin and angiotensin-receptor blocker after stenting as a useful strategy for prevention of coronary restenosis.
Nishikawa H, Miura S, Shimomura H, Tsujita K, Okamura K, Zhang B, Iwata A, Shirai K, Matsuo K, Arai H, Saku K.
J Cardiol. 2005 Mar;45(3):107-13.
ヒト心房性ナトリウム利尿ペプチドの単独投与により人工呼吸器管理を回避できた心不全の一例
岡村圭祐、西川宏明、三浦伸一郎、朔啓二郎
臨牀と研究(0021-4965)82巻9号 Page1585-1588(2005.09)
ALP anomaly(IgGやλchainとの結合)を認めた一例
岡村圭祐, 三浦伸一郎, 朔錦, 朔啓二郎
臨牀と研究(0021-4965)81巻7号 Page1187-1188(2004.07)

賞罰

第101回日本循環器学会九州地方会若手研究者賞
2006年12月2日
ESH The Poster Award Committee of the ESH London Meeting 2012
(22nd European Meeting on hypertension and cardiovascular protection)

査読

Hypertension Research
Circulation Journal
Internal medicine
American Journal of Case Report